Viral hepatitis in 2021: The challenges remaining and how we should tackle them

por Dunn, Rebecca, Wetten, Aaron, McPherson, Stuart, Donnelly, Mhairi C
Publicado 2022

Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis C

por McPherson, Stuart, Gosrani, Shion, Hogg, Sarah, Patel, Preya, Wetten, Aaron, Welton, Rachael, Hallsworth, Kate, Campbell, Matthew
Publicado 2020

Association of exercise participation levels with cardiometabolic health and quality of life in individuals with hepatitis C

por Hallsworth, Kate, Gosrani, Shion, Hogg, Sarah, Patel, Preya, Wetten, Aaron, Welton, Rachael, McPherson, Stuart, Campbell, Matthew D
Publicado 2021

Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?

por Wetten, Aaron, Ogle, Laura, Mells, George, Hegade, Vinod S., Jopson, Laura, Corrigan, Margaret, Palmer, Jeremy, Johansson, Maja, Bäckström, Torbjörn, Doverskog, Magnus, Jones, David E. J., Dyson, Jessica K.
Publicado 2022

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

por Jones, David E.J., Wetten, Aaron, Barron-Millar, Ben, Ogle, Laura, Mells, George, Flack, Steven, Sandford, Richard, Kirby, John, Palmer, Jeremy, Brotherston, Sophie, Jopson, Laura, Brain, John, Smith, Graham R., Rushton, Steve, Jones, Rebecca, Rushbrook, Simon, Thorburn, Douglas, Ryder, Stephen D., Hirschfield, Gideon, Dyson, Jessica K.
Publicado 2022